Mandibular Advancement Devices’ Efficacy in Treating Obstructive Sleep Apnea - An Overview of Clinical Data

Background: Complete or partial collapse of the upper airway for a few seconds during sleep is the cause of obstructive sleep apnea (OSA). OSA affects about half of the world's population. Although there are numerous treatment options for OSA, continuous positive airway pressure (CPAP), mandibular advancement device (MAD), and surgeries are regarded as mainstream therapies. Objective: Since MAD is a better alternative to CPAP for patients who are unwilling to utilize CPAP therapy or who do not comply with it, our current review focuses on how effective MAD is at managing OSA. Methods: To find publications relevant to the safety and effectiveness of MAD in the treatment of OSA, online databases such as Medline/PubMed/PMC, Scopus, Web of Science, Google Scholar, and reference lists were searched. Results: Through the reduction of apnea-hypopnea index (AHI), snoring, and improved sleep quality, a number of prospective and retrospective observational studies, randomized controlled clinical trials and meta-analyses showed that MADs are beneficial for patients with mild-to-moderate OSA and snoring. Although CPAP therapy is the gold standard for treating OSA, patients who cannot or do not want to utilize CPAP therapy may benefit from MAD therapy as an alternative or as a supplementary treatment. For patients with OSA, the use of oral appliances, including MAD, is advised by the American Academy of Sleep Medicine (AASM), American Academy of Dental Sleep Medicine (AADSM), and National Institute of Clinical Excellence (NICE) guidelines. Conclusion: Numerous randomized controlled clinical trials, prospective and retrospective observational studies, and meta-analyses have demonstrated that MADs are beneficial in treating OSA patients by reducing snoring, enhancing sleep quality, and lowering the apnea-hypopnea index (AHI). A licensed dentist should utilize a custom, titratable MAD when a sleep physician prescribes oral appliance therapy for an adult patient with OSA. The patients managed with MAD therapy should be advised to pay follow-up visits.

Authors

Institutions

Publication Details

Journal
Current Respiratory Medicine Reviews
Published
2025-08-29
DOI
https://doi.org/10.2174/011573398x367489250610162336
Citations
1
Primary Topic
Obstructive Sleep Apnea Research
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mandibular Advancement Devices’ Efficacy in Treating Obstructive Sleep Apnea - An Overview of Clinical Data

Naina Mohamed Pakkir Maideen, Azmina Parveen Raja Mohamed, Rumisa Nabi, Mohamed Nazar Sirajudeen
1 citations
Current Respiratory Medicine Reviews
Obstructive Sleep Apnea Research
1.16
article

Mandibular Advancement Devices’ Efficacy in Treating Obstructive Sleep Apnea - An Overview of Clinical Data

Naina Mohamed Pakkir Maideen, Azmina Parveen Raja Mohamed, Rumisa Nabi, Mohamed Nazar Sirajudeen
article en
1 citations

Abstract

Background: Complete or partial collapse of the upper airway for a few seconds during sleep is the cause of obstructive sleep apnea (OSA). OSA affects about half of the world's population. Although there are numerous treatment options for OSA, continuous positive airway pressure (CPAP), mandibular advancement device (MAD), and surgeries are regarded as mainstream therapies. Objective: Since MAD is a better alternative to CPAP for patients who are unwilling to utilize CPAP therapy or who do not comply with it, our current review focuses on how effective MAD is at managing OSA. Methods: To find publications relevant to the safety and effectiveness of MAD in the treatment of OSA, online databases such as Medline/PubMed/PMC, Scopus, Web of Science, Google Scholar, and reference lists were searched. Results: Through the reduction of apnea-hypopnea index (AHI), snoring, and improved sleep quality, a number of prospective and retrospective observational studies, randomized controlled clinical trials and meta-analyses showed that MADs are beneficial for patients with mild-to-moderate OSA and snoring. Although CPAP therapy is the gold standard for treating OSA, patients who cannot or do not want to utilize CPAP therapy may benefit from MAD therapy as an alternative or as a supplementary treatment. For patients with OSA, the use of oral appliances, including MAD, is advised by the American Academy of Sleep Medicine (AASM), American Academy of Dental Sleep Medicine (AADSM), and National Institute of Clinical Excellence (NICE) guidelines. Conclusion: Numerous randomized controlled clinical trials, prospective and retrospective observational studies, and meta-analyses have demonstrated that MADs are beneficial in treating OSA patients by reducing snoring, enhancing sleep quality, and lowering the apnea-hypopnea index (AHI). A licensed dentist should utilize a custom, titratable MAD when a sleep physician prescribes oral appliance therapy for an adult patient with OSA. The patients managed with MAD therapy should be advised to pay follow-up visits.

Current Respiratory Medicine ReviewsVol. 21(5)
Mohammed Bin Rashid University of Medicine and Health Sciences (AE), Krishna Institute of Medical Sciences Deemed University (IN), Dubai Medical College (AE), Ragas Dental College & Hospital (IN)
Openalex Percentile: Top 18%
Obstructive Sleep Apnea Research
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.